Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687240 · ClinicalTrials.gov registry record · NA
Heart Focused Movement Effects on Cardiometabolic Risk
A NA study of Cardiometabolic Risk Factors, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT05687240: Completed NA study of Cardiometabolic Risk Factors, sponsored by Arizona State University.
NCT05687240 is a NA study of Cardiometabolic Risk Factors that has completed, run by Arizona State University. The registered enrollment target is 22 participants, below the 193-participant average among 4 other Cardiometabolic Risk Factors trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05687240, a NA study of Cardiometabolic Risk Factors, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed as a two-group parallel randomized controlled trial (N=50) to test effects of 8-weeks of Qigong/Tai Chi (QTC) intervention compared to QTC plus HRVB on HRV parameters (primary), and cardiometabolic risk factors and sequelae (secondary) (e.g., BMI, waist circumference/percent body fat, sleep quality, stress, anxiety/depression, emotional regulation, eating behaviors, and cognitive performance).
Primary Outcome
Measured using resting Heart rate variability and computing parameters of high frequency power and coherence. Will be assessed with participants following a videoguide "to measure their heart rate" that helps them set up equipment and account, seated for 5 minutes of interbeat interval capture using the Inner Balance Bluetooth (HeartMath product) software and earlobe heart beat sensor.
Conditions Studied
Interventions
- BEHAVIORAL Heart rate variability biofeedback
- BEHAVIORAL Qigong/Tai Chi
Study Locations (1)
Arizona
- Arizona State University - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
What the finished NCT05687240 record still lists
NCT05687240 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 193-participant average among 4 other Cardiometabolic Risk Factors trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Cardiometabolic Risk Factors appearing as the primary indexed condition, and to 2 interventions - of which Heart rate variability biofeedback is the first listed.
NCT05687240 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05687240 about?
NCT05687240 is a clinical study titled "Heart Focused Movement Effects on Cardiometabolic Risk". This study is designed as a two-group parallel randomized controlled trial (N=50) to test effects of 8-weeks of Qigong/Tai Chi (QTC) intervention compared to QTC plus HRVB on HRV parameters (primary), and cardiometabolic risk factors and sequelae (secondary) (e.g., BMI, waist circumference/percent b...
What is the current status of trial NCT05687240?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-12-01. Estimated completion is 2023-07-31.
What conditions does trial NCT05687240 study?
This clinical trial studies the following conditions: Cardiometabolic Risk Factors.
What interventions are being tested in trial NCT05687240?
The interventions under investigation include: Heart rate variability biofeedback (BEHAVIORAL), Qigong/Tai Chi (BEHAVIORAL).
Who is sponsoring clinical trial NCT05687240?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05687240 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiometabolic Risk Factors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
RECRUITING · NA
-
Delta GREENS Food is Medicine Intervention
RECRUITING · NA
-
Trial of Pistachio Consumption in Older Adults
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI